info@myokarditida.cz

Myokarditida

Webový průvodce o nemoci myokarditida, její diagnostice a léčbě.
  • HOME
  • ABOUT
    • About project
    • Warning
    • Stories
      • My story
  • MYOCARDITIS
    • Definition of myocarditis
    • Causes (Etiology)
    • What´s going on in the body (pathogenesis)
    • Symptoms
    • Types of myocarditis
    • Dictionary
  • DIAGNOSIS & TREATMENT
    • Diagnosis
      • Physical examination
      • Electrocardiogram (ECG)
      • X-Ray
      • Echocardiography (ECHO)
      • Cardiac magnetic resonance imaging (CMRI)
      • Lab testing
      • Endomyocardial biopsy (EMB)
      • Scintigraphy and cardiac catheterization
    • Treatment possibilities
      • Treatment possibilities
      • Heart failure treatment
      • Treatment with antivirotics and antibiotics
      • Immunological treatment
      • Other treatment possibilities
    • Life with myocarditis
  • RESEARCH
    • COVID-19
      • COVID-19 (1.část) – úvod
      • COVID-19 (2.část) – příznaky, diagnostika a léčba
      • COVID-19 (3.část) – imunitní systém
      • COVID-19 (4.část) – vakcíny proti SARS-CoV-2
      • COVID-19 (5.část) – imunitní odpověď po nákaze a očkování
      • COVID-19 (6.část) – myokarditida
      • COVID-19 (7.část) – dopady na srdce a cévy
      • COVID-19 (8.část) – dopady infekce
      • COVID-19 novinky 2023 – 1. část
      • COVID-19 novinky 2023 – 2. část
      • COVID-19 – zdroje
    • News
      • Telbivudin
      • Interleukin 1beta inhibitors
      • Rituximab
      • British Heart Foundation
      • Treatment with interferon beta
      • Immunosuppressive therapy of myocarditis
    • What do the Doctors Say?
      • Dr. Renzo Marcolongo
      • Dr. Andrea Silvio Giordani
      • Professor Leslie T. Cooper, Jr.
      • Theodor Adla M.D.
      • Veronika Stará M.D.
      • Lenka Roblová M.D.
  • CONTACT
Home
/
Výzkum
/
Aktuality

Telbivudin

14.8.2021 Jan Habásko
Telbivudine is an antiviral drug used primarily in the therapy of hepatitis B. It is a disease when liver cells are affected by the hepatitis B virus. This disease may lead to liver cirrhosis and failure. However, a favourable effect of Telbivudine has been described even in patients with inflammatory cardiomyopathy caused by the parvovirus
Více ...

Interleukin 1beta inhibitors

6.8.2020 Jan Habásko

…

Více ...

Rituximab

17.11.2019 Jan Habásko

…

Více ...

British Heart Foundation

4.9.2018 Jan Habásko

British Heart Foundation i…

Více ...

Immunosuppressive therapy of myocarditis

15.7.2016 Jan Habásko

Immunosuppressive Therapy in Myocarditis. Circulation Journal: Official Journal of the Japanese Circulation Society. 2015, –(79), 4-7.

The effect of immunosuppressive therapy lies in the suppression of the immune system reaction. The possibilities…

Více ...

Treatment with interferon beta

1.3.2016 Jan Habásko

The management of myocarditis. European Heart Journal. 2011, -(32), 2616–2625.

Interferons, including interferon beta, are a part of anti-viral and anti-cancer immunity. They suppress the reproduction of the virus and cause cell death in …

Více ...

Navigace/Navigation

  • HOME
  • ABOUT
    • About project
    • Warning
    • Stories
      • My story
  • MYOCARDITIS
    • Definition of myocarditis
    • Causes (Etiology)
    • What´s going on in the body (pathogenesis)
    • Symptoms
    • Types of myocarditis
    • Dictionary
  • DIAGNOSIS & TREATMENT
    • Diagnosis
      • Physical examination
      • Electrocardiogram (ECG)
      • X-Ray
      • Echocardiography (ECHO)
      • Cardiac magnetic resonance imaging (CMRI)
      • Lab testing
      • Endomyocardial biopsy (EMB)
      • Scintigraphy and cardiac catheterization
    • Treatment possibilities
      • Treatment possibilities
      • Heart failure treatment
      • Treatment with antivirotics and antibiotics
      • Immunological treatment
      • Other treatment possibilities
    • Life with myocarditis
  • RESEARCH
    • COVID-19
      • COVID-19 (1.část) – úvod
      • COVID-19 (2.část) – příznaky, diagnostika a léčba
      • COVID-19 (3.část) – imunitní systém
      • COVID-19 (4.část) – vakcíny proti SARS-CoV-2
      • COVID-19 (5.část) – imunitní odpověď po nákaze a očkování
      • COVID-19 (6.část) – myokarditida
      • COVID-19 (7.část) – dopady na srdce a cévy
      • COVID-19 (8.část) – dopady infekce
      • COVID-19 novinky 2023 – 1. část
      • COVID-19 novinky 2023 – 2. část
      • COVID-19 – zdroje
    • News
      • Telbivudin
      • Interleukin 1beta inhibitors
      • Rituximab
      • British Heart Foundation
      • Treatment with interferon beta
      • Immunosuppressive therapy of myocarditis
    • What do the Doctors Say?
      • Dr. Renzo Marcolongo
      • Dr. Andrea Silvio Giordani
      • Professor Leslie T. Cooper, Jr.
      • Theodor Adla M.D.
      • Veronika Stará M.D.
      • Lenka Roblová M.D.
  • CONTACT

Kontakty/Contacts

info@myokarditida.cz

Sdílení/Share

  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • Tumblr
  • StumbleUpon
  • Reddit

Sociální sítě/Social networks

Záštita/Patronage

Zpětné odkazy/Links

CZIN.eu TOPlist TOPlist Přidat.eu
Myokarditida © 2026   |